HCID 178511956, compound → HCID 178511954, compound
Reaction equation
[OH:1][C:2]1[C:7]([C:8]2[NH:12][C:11]3[CH:13]=[CH:14][C:15]([C:17]([NH2:19])=[NH:18])=[CH:16][C:10]=3[N:9]=2)=[CH:6][C:5]([S:20](=[O:33])(=[O:32])[NH:21][C:22](=[O:31])[CH2:23][CH2:24][C:25]2[CH:26]=[N:27][CH:28]=[CH:29][CH:30]=2)=[CH:4][C:3]=1[C:34]1[CH:39]=[CH:38][CH:37]=[C:36]([N+:40]([O-])=O)[CH:35]=1>FC(F)(F)C(O)=O.O=[Pt]=O>[NH2:40][C:36]1[CH:35]=[C:34]([C:3]2[CH:4]=[C:5]([S:20](=[O:33])(=[O:32])[NH:21][C:22](=[O:31])[CH2:23][CH2:24][CH:25]3[CH2:30][CH2:29][CH2:28][NH:27][CH2:26]3)[CH:6]=[C:7]([C:8]3[NH:12][C:11]4[CH:13]=[CH:14][C:15]([C:17]([NH2:19])=[NH:18])=[CH:16][C:10]=4[N:9]=3)[C:2]=2[OH:1])[CH:39]=[CH:38][CH:37]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
2-[2-Hydroxy-3′-nitro-5-(3-pyridin-3-yl-propionylsulfamoyl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine (0.031 g, 0.05 mmol), prepared as in Example 10, was dissolved in trifluoroacetic acid (5 mL) and the solution was subjected to hydrogenation at 50 psi over PtO2 catalyst for 12 hours. The mixture was concentrated in vacuum and product was purified from the residue by reverse phase HPLC (acetonitrile gradient) to give 2-[3′-amino-2-hydroxy-5-(3-piperidin-3-yl-propionylsulfamoyl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine (0.01 g). MS: found (M+H+) 562.4, (M−H+) 560.6, calc. 561.22.
Workup
- concentrationThe mixture was concentrated in vacuum and product
- customwas purified from the residue by reverse phase HPLC (acetonitrile gradient)
Sources & evidence
- ORD record
- ord-bbf7f64868f9439db11af8ed4092049d
- Source dataset
- uspto-grants-2009_01
- Patent number
- US07479502B2
Reaction notes
Loading…